TheraRadar
Data updated: May 26, 2026

PENICILLIN-VK (penicillin v potassium)

Infectious Disease Approved 1968-07-03

PENICILLIN-VK is indicated for the treatment of Streptococcal Infections; Scarlet Fever; Erysipelas; Pneumococcal Infections.

Source: FDA Label • Teva
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
2
Indications
--
Phase 3 Trials
57
Years on Market

Details

Status
Prescription
First Approved
1968-07-03
Routes
ORAL
Dosage Forms
TABLET, FOR SOLUTION

Companies

Teva
Active Ingredient: PENICILLIN V POTASSIUM

PENICILLIN-VK Approval History

1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
72 FDA actions from 1968 to 2014
Jul 2014 SUPPL
Label · Labeling
Apr 2008 SUPPL
Label · Labeling
Sep 2007 SUPPL
Label · Labeling

What PENICILLIN-VK Treats

4 indications

PENICILLIN-VK is approved for 4 conditions since its original approval in 1968. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Streptococcal Infections
  • Scarlet Fever
  • Erysipelas
  • Pneumococcal Infections
Source: FDA Label

PENICILLIN-VK Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Indication competitors

10

Same indication, different mechanism — what else might this patient receive?

CEFOXITIN IN PLASTIC CONTAINER
SAMSON MEDCL
2015 10 indic.
CLINDAMYCIN PALMITATE HYDROCHLORIDE
SOMERSET THERAPS
2010 10 indic.
Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to PENICILLIN-VK

3 of 4

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

BICILLIN C-R 900/300
PENICILLIN G BENZATHINE
2 shared
KING PHARMS LLC
Shared indications:
Scarlet FeverErysipelas
CLEOCIN PHOSPHATE
CLINDAMYCIN PHOSPHATE
2 shared
Pfizer
Shared indications:
Streptococcal InfectionsPneumococcal Infections
LINCOCIN
LINCOMYCIN HYDROCHLORIDE
2 shared
PHARMACIA AND UPJOHN
Shared indications:
Streptococcal InfectionsPneumococcal Infections
View all 4 similar drugs Pro
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PENICILLIN-VK FDA Label Details

Indications & Usage

PENICILLIN-VK is indicated for the treatment of Streptococcal Infections; Scarlet Fever; Erysipelas; Pneumococcal Infections.

Track PENICILLIN-VK with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

FDA Approval: ANDA060711 → Label: DailyMed → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.